Cauble & Harre Wealth Management Inc. bought a new position in shares of Enovix Corporation (NASDAQ:ENVX – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 138,381 shares of the company’s stock, valued at approximately $1,012,000. Enovix comprises approximately 0.8% of Cauble & Harre Wealth Management Inc.’s investment portfolio, making the stock its 27th biggest position. Cauble & Harre Wealth Management Inc. owned approximately 0.06% of Enovix at the end of the most recent quarter.
Several other institutional investors and hedge funds have also made changes to their positions in the stock. Principal Financial Group Inc. boosted its holdings in shares of Enovix by 7.6% during the 3rd quarter. Principal Financial Group Inc. now owns 12,613 shares of the company’s stock worth $126,000 after purchasing an additional 895 shares during the last quarter. Private Advisor Group LLC boosted its holdings in shares of Enovix by 2.7% during the 3rd quarter. Private Advisor Group LLC now owns 46,519 shares of the company’s stock worth $464,000 after purchasing an additional 1,242 shares during the last quarter. Parallel Advisors LLC boosted its holdings in shares of Enovix by 51.9% during the 3rd quarter. Parallel Advisors LLC now owns 3,926 shares of the company’s stock worth $39,000 after purchasing an additional 1,342 shares during the last quarter. Equitable Holdings Inc. boosted its holdings in shares of Enovix by 10.9% during the 3rd quarter. Equitable Holdings Inc. now owns 13,700 shares of the company’s stock worth $137,000 after purchasing an additional 1,342 shares during the last quarter. Finally, Claro Advisors LLC boosted its holdings in shares of Enovix by 2.9% during the 3rd quarter. Claro Advisors LLC now owns 64,578 shares of the company’s stock worth $644,000 after purchasing an additional 1,850 shares during the last quarter. 50.92% of the stock is currently owned by institutional investors and hedge funds.
Key Stories Impacting Enovix
Here are the key news stories impacting Enovix this week:
- Positive Sentiment: Enovix’s Q1 results beat revenue expectations and the company reported a smaller-than-expected loss, while management highlighted revenue growth and strategic progress on the earnings call. Enovix Corp (ENVX) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Alignments
- Positive Sentiment: Unusually heavy call option activity suggests some traders are betting on a rebound in Enovix shares. Enovix (NASDAQ:ENVX) Price Target Cut to $21.00 by Analysts at Oppenheimer
- Neutral Sentiment: Oppenheimer, Benchmark, Craig Hallum, and TD Cowen all reduced their price targets on Enovix, but most still kept constructive ratings, signaling lower valuation expectations rather than a full thesis change. Enovix (NASDAQ:ENVX) Given New $15.00 Price Target at Benchmark Enovix (NASDAQ:ENVX) Price Target Lowered to $8.00 at Craig Hallum Enovix (NASDAQ:ENVX) Price Target Cut to $7.00 by Analysts at TD Cowen
- Negative Sentiment: Investors are also focused on Enovix’s widening losses and the uncertain timeline for commercialization, which appeared to weigh on the stock after earnings. Enovix sinks as losses widen; commercialization timeline remains in focus
Enovix Trading Down 3.0%
Enovix (NASDAQ:ENVX – Get Free Report) last released its quarterly earnings data on Wednesday, May 13th. The company reported ($0.14) EPS for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.01. Enovix had a negative return on equity of 63.25% and a negative net margin of 499.64%.The firm had revenue of $7.60 million for the quarter, compared to analysts’ expectations of $6.95 million. During the same period in the prior year, the firm posted ($0.15) earnings per share. The firm’s quarterly revenue was up 49.1% on a year-over-year basis. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. As a group, equities research analysts expect that Enovix Corporation will post -0.81 EPS for the current year.
Wall Street Analysts Forecast Growth
Several brokerages have recently weighed in on ENVX. Bank of America began coverage on Enovix in a report on Thursday, March 12th. They set a “neutral” rating and a $6.00 target price on the stock. Wall Street Zen raised shares of Enovix from a “strong sell” rating to a “sell” rating in a research report on Saturday. Benchmark lowered their price target on shares of Enovix from $25.00 to $15.00 and set a “buy” rating on the stock in a research report on Thursday. TD Cowen reissued a “buy” rating on shares of Enovix in a research report on Thursday. Finally, JPMorgan Chase & Co. cut shares of Enovix from a “neutral” rating to an “underweight” rating in a research report on Wednesday, May 6th. Seven analysts have rated the stock with a Buy rating, one has given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $12.64.
Get Our Latest Analysis on Enovix
Enovix Company Profile
Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.
Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.
Recommended Stories
- Five stocks we like better than Enovix
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Want to see what other hedge funds are holding ENVX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enovix Corporation (NASDAQ:ENVX – Free Report).
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.
